Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LORAZEPAM Cause Incorrect drug administration duration? 8 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Incorrect drug administration duration have been filed in association with LORAZEPAM (Lorazepam). This represents 0.0% of all adverse event reports for LORAZEPAM.

8
Reports of Incorrect drug administration duration with LORAZEPAM
0.0%
of all LORAZEPAM reports
0
Deaths
1
Hospitalizations

How Dangerous Is Incorrect drug administration duration From LORAZEPAM?

Of the 8 reports, 1 (12.5%) required hospitalization, and 1 (12.5%) were considered life-threatening.

Is Incorrect drug administration duration Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LORAZEPAM. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does LORAZEPAM Cause?

Drug ineffective (3,775) Drug abuse (3,741) Toxicity to various agents (2,836) Completed suicide (2,340) Off label use (2,178) Somnolence (2,114) Sopor (2,042) Anxiety (1,573) Fall (1,524) Overdose (1,516)

What Other Drugs Cause Incorrect drug administration duration?

ETONOGESTREL (1,796) POLYETHYLENE GLYCOL 3350 (1,722) NAPROXEN (1,272) DOCOSANOL (803) ETHINYL ESTRADIOL\ETONOGESTREL (740) NICOTINE (561) RANITIDINE (504) GUAIFENESIN (490) INSULIN LISPRO (367) ACETAMINOPHEN (340)

Which LORAZEPAM Alternatives Have Lower Incorrect drug administration duration Risk?

LORAZEPAM vs LORCASERIN LORAZEPAM vs LORLATINIB LORAZEPAM vs LORMETAZEPAM LORAZEPAM vs LORNOXICAM LORAZEPAM vs LOSARTAN

Related Pages

LORAZEPAM Full Profile All Incorrect drug administration duration Reports All Drugs Causing Incorrect drug administration duration LORAZEPAM Demographics